$0.82
▼ -0.2% Today
as of Sep 4, 16:55 ET
Last 30 days
Recent Press Releases & News
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative
TELA Bio (TELA) Q2 2026 Earnings Call Transcript
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ...
Overview
52-week range
$0.50
$1.73
26% of range
Avg surprise (last 3)
-30.4%
Avg reaction (last 2)
+4.7%
100% positive
Latest IV / EM
4085%
EM ±835.7% · $3 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.20 | — | — | — | — | financials |
| Tue May 12, 2026 | Mar/2026 | $-0.21 | $-0.14 | -50.0% | +16.0% | +5.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.19 | — | — | — | — | financials |
| Mon Aug 11, 2025 | Jun/2025 | $-0.22 | $-0.18 | -22.2% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.25 | $-0.21 | -19.1% | — | +4.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.42 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.51 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.23 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.45 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.46 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.63 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $19M | — | $21M | $20M | $19M | — | $19M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | $14M | $13M | — | $14M | $14M | $13M | — | $13M |
| Operating income | $-9M | $-11M | — | $-8M | $-9M | $-10M | — | $-9M |
| Net income | $-11M | $-12M | — | $-9M | $-10M | $-11M | — | $-10M |
| EPS (diluted) | $-0.20 | $-0.21 | — | $-0.19 | $-0.22 | $-0.25 | — | $-0.42 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $30M | $40M | $51M | $30M | $35M | $43M | $53M | $17M |
| Inventory | $11M | $12M | $11M | $12M | $11M | $14M | $13M | $14M |
| Total current assets | $54M | $64M | $76M | $56M | $61M | $70M | $78M | $44M |
| Total assets | $60M | $70M | $81M | $62M | $68M | $77M | $87M | $53M |
| Long-term debt | $56M | $56M | $56M | $41M | $38M | $41M | $41M | $41M |
| Total liabilities | $76M | $75M | $75M | $60M | $58M | $59M | $58M | $59M |
| Total equity | $-16M | $-5M | $6M | $2M | $9M | $18M | $28M | $-6M |